Protagenic Therapeutics, Inc. (PTIX) Financials

PTIX Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 5.4 million 1.3 million
2023-06-30 6.9 million 1.5 million
2023-03-31 7.7 million 1.3 million
2022-12-31 8.0 million 1.1 million

PTIX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -711572 166707
2023-06-30 -1.5 million 166707
2023-03-31 -371834 166707
2022-12-31 -182741 198688

PTIX Net Income

No data available :(

PTIX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 5.3 million - -
2023-06-30 6.0 million - -
2023-03-31 7.7 million - -
2022-12-31 8.0 million - -

PTIX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 4.3 million
2023-06-30 4.3 million
2023-03-31 4.3 million
2022-12-31 4.3 million

PTIX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 55806 1.1 million 307682 -
2023-06-30 - 836379 307363 -
2023-03-31 - 348031 391263 -
2022-12-31 1805 257520 398258 -

PTIX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 1419
2023-06-30 - 91
2023-03-31 - 90
2022-12-31 - 30

PTIX

Price: $1.28

52 week price:
0.68
2.32

Earnings Per Share: -1.15 USD

P/E Ratio: -1.05

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 6800

Market Capitalization: 6.4 million

Links: